PODXL and breast carcinoma: Furthermore, in MCF-7 breast cancer and P3C prostate cancer cell lines, PODXL enhanced cell migration and invasion, matrix metalloproteinase 1 and 9 expression, and activation of MAPK and PI3K activity through its interaction with ezrin in in vitro assays [85].